Location History:
- Pacific Beach, CA (US) (1987)
- San Diego, CA (US) (1990)
Company Filing History:
Years Active: 1987-1990
Title: Paul K Krejci: Innovator in Fluid Delivery Systems
Introduction
Paul K Krejci is a notable inventor based in San Diego, CA, who has made significant contributions to the field of fluid delivery systems. With a total of 2 patents, Krejci's work primarily focuses on innovative solutions for pharmaceutical applications.
Latest Patents
Krejci's latest patents include a fluid delivery micropump and an electrochemically-driven pulsatile drug dispenser. The fluid delivery micropump is designed to transport electrochemically active materials, such as oxygen, at a steady rate across an ion exchange cell. This technology applies external pressure to a collapsible reservoir, allowing for the expulsion of fluid. The micropump utilizes an air-actuated battery, which is activated by peeling off an adhesive tape covering air inlet ports. This establishes a voltage gradient across the cell, controlling the fluid expulsion rate based on the resistor value in the circuit. The device is versatile, with configurations suitable for both external and implantable use.
The electrochemically-driven pulsatile drug dispenser is another of Krejci's innovations. This device features a fluid reservoir for drug storage and an electrochemical pump for drug delivery. The pump valve is responsive to the pump pressure, releasing pressure when a predetermined value is reached. This results in a low-cost, lightweight, and efficient solution for pulsatile drug delivery.
Career Highlights
Krejci is currently associated with Ivac Corporation, where he continues to develop innovative technologies in the medical field. His work has significantly impacted the way drugs are delivered, enhancing patient care and treatment efficiency.
Collaborations
Krejci collaborates with Henri J Maget, contributing to the advancement of fluid delivery technologies.
Conclusion
Paul K Krejci's contributions to fluid delivery systems exemplify innovation in the medical technology sector. His patents reflect a commitment to improving drug delivery methods, ultimately benefiting patients and healthcare providers alike.